FDA Inspection 1044743 — Hanmi Pharma Co., Ltd
The FDA completed an inspection of Hanmi Pharma Co., Ltd on Feb 1, 2018 in Pyeongtaek. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 1, 2018
- Fiscal Year
- 2018
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Pyeongtaek (Korea (the Republic of))